Atherosclerosis: Etymology, Pathophysiology, and Clinical Significance

Atherosclerosis (from Greek athērē = gruel, porridge + sklērōsis = hardening) is a chronic inflammatory disease of medium and large arteries characterized by focal intimal plaques containing lipid-laden foam cells, extracellular lipid, smooth muscle cells, collagen, and calcium.

Pathogenic Sequence (Response-to-Injury / Inflammatory)

  1. Endothelial Dysfunction: LDL retention → oxidation (oxLDL) → adhesion molecule expression (VCAM-1).
  2. Monocyte Recruitment & Foam Cell Formation: Monocytes → macrophages → scavenger receptor uptake of oxLDL → foam cells.
  3. Fatty Streak: Early lesion (reversible).
  4. Smooth Muscle Migration/Proliferation: Media → intima; synthesize collagen, proteoglycans → fibrous cap.
  5. Advanced Plaque: Necrotic core, calcification, neovascularization, intraplaque hemorrhage.
  6. Complications: Rupture → thrombosis → MI/stroke; erosion; progressive stenosis → stable angina/claudication.

Major Risk Factors

  • Modifiable: Dyslipidemia (↑LDL-C, ↓HDL-C), HTN, smoking, diabetes, obesity, inactivity, diet.
  • Non-modifiable: Age, male sex, family history, genetic (e.g., FH, PCSK9).
  • Emerging: Inflammation (hsCRP), Lp(a), TMAO, CKD, HIV, autoimmune.

Clinical Manifestations by Vascular Bed

  • Coronary: Angina, MI, HF, sudden death.
  • Cerebrovascular: TIA, stroke, vascular dementia.
  • Peripheral: Claudication, critical limb ischemia.
  • Aortic: Aneurysm, dissection.
  • Renal: Renovascular HTN, ischemic nephropathy.
  • Mesenteric: Intestinal angina, infarction.

Prevention & Treatment

  • Lifestyle: Mediterranean diet, exercise, smoking cessation, weight control.
  • Pharmacologic: Statins (high-intensity for ASCVD), ezetimibe, PCSK9i, bempedoic acid; antihypertensives; antiplatelets (secondary prevention); SGLT2i/GLP-1RA (DM/CKD).
  • Revascularization: PCI, CABG, endarterectomy, stenting for limiting symptoms/events.

Cardiovascular Disease - Related Articles